1. Home
  2. ARQ vs ACTU Comparison

ARQ vs ACTU Comparison

Compare ARQ & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQ
  • ACTU
  • Stock Information
  • Founded
  • ARQ 1996
  • ACTU 2015
  • Country
  • ARQ United States
  • ACTU United States
  • Employees
  • ARQ N/A
  • ACTU N/A
  • Industry
  • ARQ
  • ACTU
  • Sector
  • ARQ
  • ACTU
  • Exchange
  • ARQ NYSE
  • ACTU NYSE
  • Market Cap
  • ARQ 155.3M
  • ACTU 135.0M
  • IPO Year
  • ARQ N/A
  • ACTU 2024
  • Fundamental
  • Price
  • ARQ $5.75
  • ACTU $6.15
  • Analyst Decision
  • ARQ Strong Buy
  • ACTU Strong Buy
  • Analyst Count
  • ARQ 1
  • ACTU 1
  • Target Price
  • ARQ $8.00
  • ACTU $20.00
  • AVG Volume (30 Days)
  • ARQ 207.4K
  • ACTU 151.6K
  • Earning Date
  • ARQ 08-11-2025
  • ACTU 05-15-2025
  • Dividend Yield
  • ARQ N/A
  • ACTU N/A
  • EPS Growth
  • ARQ N/A
  • ACTU N/A
  • EPS
  • ARQ N/A
  • ACTU N/A
  • Revenue
  • ARQ $114,466,000.00
  • ACTU N/A
  • Revenue This Year
  • ARQ $11.92
  • ACTU N/A
  • Revenue Next Year
  • ARQ $31.32
  • ACTU N/A
  • P/E Ratio
  • ARQ N/A
  • ACTU N/A
  • Revenue Growth
  • ARQ 14.33
  • ACTU N/A
  • 52 Week Low
  • ARQ $3.34
  • ACTU $5.50
  • 52 Week High
  • ARQ $8.11
  • ACTU $11.99
  • Technical
  • Relative Strength Index (RSI)
  • ARQ 60.70
  • ACTU N/A
  • Support Level
  • ARQ $5.58
  • ACTU N/A
  • Resistance Level
  • ARQ $6.14
  • ACTU N/A
  • Average True Range (ATR)
  • ARQ 0.26
  • ACTU 0.00
  • MACD
  • ARQ 0.02
  • ACTU 0.00
  • Stochastic Oscillator
  • ARQ 69.78
  • ACTU 0.00

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Share on Social Networks: